Arthneeti
S

Shalby Ltd

Q3 FY26Healthcare Services

Shalby Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹153
Market cap₹1.7K Cr
P/E42.0
Updated23 Aug 2026
Read4 min read

The short version

Hospital business expects 60% to 70% more work growth in existing hospitals over the next 2 years due to infrastructure upgrades including robotics and diagnostics. Hospital business aims to stabilize and grow EBITDA margins to 20% per unit, potentially reaching 23%-25% at 50% higher occupancy in coming quarters.

From Shalby Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Hospital business expects 60% to 70% more work growth in existing hospitals over the next 2 years due to infrastructure upgrades including robotics and diagnostics.
  • Additional bed capacity available for ramp-up, e.g., 50+ beds in Delhi NCR region planned to be utilized at the right time.
  • ARPOB (Average Revenue Per Occupied Bed) expected to grow around 5%-6% historically; robotics and rate revisions by government/insurance to contribute to higher ARPOB.
  • Implant business showing strong revenue growth: 65% growth last year and similar in FY '26, with a large $35 billion global market opportunity and geographic expansion underway.

2 more points from Shalby Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Shalby Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • No significant capex is planned over the next 12 months for the hospital or implant business.
  • Recent heavy investments made in infrastructure upgrades, high-end robotics, and diagnostics (including installation of new PET CT scan).
  • Planned addition of 2 more radiation oncology bunkers in Mohali and Delhi NCR within the next 12 to 18 months.
  • Bed addition of about 50 beds planned in Delhi NCR at an appropriate time.
  • Capex related to implant business (instruments and other equipment) largely incurred; minimal similar capex expected over next 2-3 years.

2 more points from Shalby Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
1Health X Platform
Rev 1Mar 1
2Chandan Healthca
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 2
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Shalby Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript from Shalby Limited's Q3 FY '26 earnings call does not explicitly mention details about the current or expected order book or pending orders. The discussion primarily focuses on: - Hospital occupancy, margin improvement, bed capacity, and profitability. - Implant business aspirations, regulatory and capacity challenges. - Expansion plans, including addition of beds and infrastructure upgrades.

2 more points from Shalby Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Shalby Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹287 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Shalby's management said in earlier quarters

Others in Healthcare Services this season

  • Vijaya Diagnostic Centre Ltd (Q3 FY26)

    FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…

  • Aster DM Quality Care Ltd (Q3 FY26)

    Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…

  • Chandan Healthca (Q3 FY26)

    The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…

  • Rainbow Childrens Medicare Ltd (Q3 FY26)

    Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

Compare:vs Apollo Hospitalsvs Manipal Health Enterprises Ltdvs Max Healthcare Institute Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Shalby Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Shalby Ltd Q3 FY26 results?

Hospital business expects 60% to 70% more work growth in existing hospitals over the next 2 years due to infrastructure upgrades including robotics and diagnostics. Hospital business aims to stabilize and grow EBITDA margins to 20% per unit, potentially reaching 23%-25% at 50% higher occupancy in coming quarters.

What is Shalby Ltd share price analysis?

Shalby Ltd currently shows a neutral. The stock trades at a P/E of 42.0 with a market cap of ₹1,652 Cr. Investors should review the full earnings analysis for detailed insights.

Is Shalby Ltd planning capital expenditure?

No significant capex is planned over the next 12 months for the hospital or implant business.

Keep Shalby Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.